
    
      This post-marketing survey was conducted in the usual routine practice and the investigator
      enrolled participants vaccinated with VARIVAX continuously after study start. The purpose of
      the study was to assess the occurrence of adverse events and to identify factors that may
      affect the safety of the vaccine under real-life, post-marketing conditions. No hypothesis
      testing was conducted in this survey.
    
  